An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry
RL Benza, DP Miller, RJ Barst, DB Badesch, AE Frost… - Chest, 2012 - Elsevier
Background The Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension
Disease Management (REVEAL Registry) was established to characterize the clinical
course, treatment, and predictors of outcomes in patients with pulmonary arterial
hypertension (PAH) in the United States. To date, estimated survival based on time of patient
enrollment has been established and reported. To determine whether the survival of patients
with PAH has improved over recent decades, we assessed survival from time of diagnosis …
Disease Management (REVEAL Registry) was established to characterize the clinical
course, treatment, and predictors of outcomes in patients with pulmonary arterial
hypertension (PAH) in the United States. To date, estimated survival based on time of patient
enrollment has been established and reported. To determine whether the survival of patients
with PAH has improved over recent decades, we assessed survival from time of diagnosis …